172 related articles for article (PubMed ID: 30887277)
1. Hyperprolactinemia is associated with a high prevalence of serum autoantibodies, high levels of inflammatory cytokines and an abnormal distribution of peripheral B-cell subsets.
Liu Y; Zhang Z; Jin Q; Liu Y; Kang Z; Huo Y; He Z; Feng X; Yin J; Wu X; Wang H; Xu H
Endocrine; 2019 Jun; 64(3):648-656. PubMed ID: 30887277
[TBL] [Abstract][Full Text] [Related]
2. Anti-endothelial cell antibodies in the sera of hyperprolactinemic women.
Krause I; Blumenfeld Z; Malchinsky M; Cohen S; Blank M; Eldor A; Weksler B; Schweitzer K; Shoenfeld Y
Lupus; 1998; 7(6):377-82. PubMed ID: 9736319
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody profile in the sera of women with hyperprolactinemia.
Buskila D; Berezin M; Gur H; Lin HC; Alosachie I; Terryberry JW; Barka N; Shen B; Peter JB; Shoenfeld Y
J Autoimmun; 1995 Jun; 8(3):415-24. PubMed ID: 7576002
[TBL] [Abstract][Full Text] [Related]
4. Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients.
Blanco-Favela F; Quintal MaG ; Chavez-Rueda AK; Leaños-Miranda A; Berron-Peres R; Baca-Ruiz V; Lavalle-Montalvo C
Lupus; 2001; 10(11):803-8. PubMed ID: 11789490
[TBL] [Abstract][Full Text] [Related]
5. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia.
Leaños A; Pascoe D; Fraga A; Blanco-Favela F
Lupus; 1998; 7(6):398-403. PubMed ID: 9736323
[TBL] [Abstract][Full Text] [Related]
6. Thyroid autoimmunity in patients with hyperprolactinemia: an observational study.
Onal ED; Saglam F; Sacikara M; Ersoy R; Cakir B
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):48-52. PubMed ID: 24728164
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases.
Neidhart M
J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986
[TBL] [Abstract][Full Text] [Related]
8. [An increased prevalence of thyroid echographic and autoimmune changes in hyperprolactinemic women on therapy with dopaminergic drugs].
Giusti M; Foppiani L; Fazzuoli L; Molinari E; Guido R; Valenti S; Giordano G
Recenti Prog Med; 1999 Mar; 90(3):147-51. PubMed ID: 10228354
[TBL] [Abstract][Full Text] [Related]
9. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia.
Poyraz BC; Aksoy C; Balcioğlu I
Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008
[TBL] [Abstract][Full Text] [Related]
10. Distribution of Myeloid and Plasmacytoid Dendritic Cell Subpopulations in Peripheral Blood of Hyperprolactinemic Women.
Raeesi Nejad F; Mohammadi MM; Sanjari M; Malkpour Afshar R; Jafari E
Iran J Allergy Asthma Immunol; 2021 Apr; 20(2):198-204. PubMed ID: 33904678
[TBL] [Abstract][Full Text] [Related]
11. Altered diurnal rhythm of prolactin in systemic sclerosis.
Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
[TBL] [Abstract][Full Text] [Related]
12. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
[TBL] [Abstract][Full Text] [Related]
13. Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody.
Hattori N; Ikekubo K; Ishihara T; Moridera K; Hino M; Kurahachi H
Eur J Endocrinol; 1994 May; 130(5):438-45. PubMed ID: 8180669
[TBL] [Abstract][Full Text] [Related]
14. Association of raised levels of IL-4 and anti-TPO with hyperprolactinemia.
Kalsi AK; Halder A; Jain M; Chaturvedi PK; Mathew M; Sharma JB
Am J Reprod Immunol; 2019 Mar; 81(3):e13085. PubMed ID: 30614113
[TBL] [Abstract][Full Text] [Related]
15. Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia.
Hattori N; Nakayama Y; Kitagawa K; Ishihara T; Saiki Y; Inagaki C
J Endocrinol; 2006 Aug; 190(2):287-93. PubMed ID: 16899562
[TBL] [Abstract][Full Text] [Related]
16. Assessment of nonarticular tenderness and prevalence of fibromyalgia in hyperprolactinemic women.
Buskila D; Fefer P; Harman-Boehm I; Press J; Neumann L; Lunenfeld E; Gedalia A; Potashnik G; Sukenik S
J Rheumatol; 1993 Dec; 20(12):2112-5. PubMed ID: 8014940
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotics-induced hyperprolactinemia and screening for macroprolactin.
Ruljancic N; Bakliza A; Vuk Pisk S; Geres N; Matic K; Ivezic E; Grosic V; Filipcic I
Biochem Med (Zagreb); 2021 Feb; 31(1):010707. PubMed ID: 33380894
[TBL] [Abstract][Full Text] [Related]
18. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460
[TBL] [Abstract][Full Text] [Related]
19. Antiprolactin autoantibodies are associated with hyperprolactinemic status in men infected with human immunodeficiency virus.
Leaños-Miranda A; Contreras-Hernández I
Endocrine; 2002 Nov; 19(2):139-46. PubMed ID: 12588043
[TBL] [Abstract][Full Text] [Related]
20. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
Huan C; Cui G; Ren Z
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
